Business
CBRE report: New York/New Jersey region bolsters position as leading life sciences market with jobs increase
Source: ROI-NJ · Aug 4, 2026, 1:18 PM
AI-assisted briefing from the publisher’s public headline and excerpt — not original reporting. How we write briefings

The New York/New Jersey region is reinforcing its role as a leading U.S. life sciences center, according to CBRE's 2026 Life Sciences Talent Trends report.
The region is experiencing renewed hiring activity, rising employment levels, and increased investor interest in the life sciences sector.
The CBRE analysis covers the broader New York City market including Long Island, Westchester, and adjacent counties, highlighting how the region's life sciences ecosystem continues to attract talent and capital.
This growth reflects the region's established infrastructure, research institutions, and business environment that support biotechnology and pharmaceutical companies.
Key points
- The NY/NJ region is one of the leading U.S. life sciences markets with renewed hiring momentum
- Employment levels in life sciences are surging across the region according to CBRE data
- Investor interest in the region's life sciences sector is increasing
- The market includes New York City, Long Island, Westchester, and adjacent counties in the NY/NJ area
FAQ
- What is driving job growth in the NY/NJ life sciences sector?
- According to CBRE's 2026 report, renewed hiring, surging employment levels, and increasing investor interest are fueling growth in the region's life sciences market. The region's established research institutions and business infrastructure continue to attract companies and capital to the sector.
- Which areas are included in the NY/NJ life sciences market according to this report?
- The CBRE analysis covers the New York City market, which includes Long Island, Westchester County, and adjacent counties in the New York/New Jersey region.
- Why is the NY/NJ region competitive in life sciences?
- The region benefits from established research institutions, a growing talent pool, investor interest, and business infrastructure that support biotechnology and pharmaceutical companies operating in the area.
Briefing prepared for NJ News Hub. Verify details on the original story. See our editorial policy.
Related
- Chen to succeed Rodriguez as president of New Jersey Policy Perspective
Aug 4, 2026
- Judge keeps NJ’s ‘assault weapon’ ban in place pending Supreme Court review
Aug 4, 2026
- The TwoSixtyTwo Officially Launches Condo Sales in The Heights, Jersey City
Jersey City · Aug 4, 2026
- Top House appropriator calls for Delaney Hall shutdown
Aug 4, 2026
- NJDOL awards $1.48M in grant funding to boost construction career paths for women, minorities
Aug 4, 2026
